Statistics

Total Visits

Views
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma(legacy) 78
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma(legacy) 75

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma 0 5 1 1 1 1 0

File Downloads

Views

Top Country Views

Views
United States 59
China 15
Netherlands 8
Vietnam 6
France 5
Australia 4
Germany 3
Ireland 3
Sweden 1

Top City Views

Views
Ashburn 22
Fairfield 10
Zhengzhou 9
Des Moines 8
Rotterdam 8
Hanoi 6
Cambridge 5
Beijing 4
Dublin 3
Kaleen 2